Altered specificity of 15-LOX-1 in the biosynthesis of 7S,14S-diHDHA implicates 15-LOX-2 in biosynthesis of resolvin D5
Steve Perry(University of California, Santa Cruz), Theodore R. Holman(University of California, Santa Cruz), Oluwayomi Akinkugbe(University of California, Santa Cruz), John C. Freedman(University of California, Santa Cruz), Chakrapani Kalyanaraman(University of California, San Francisco), William S. Conrad(University of North Carolina at Chapel Hill), Benjamin E. Tourdot(Cincinnati Children's Hospital Medical Center), Michael Holinstat(University of Michigan), Matthew P. Jacobson(University of California, San Francisco)
Cited by 1
Related Papers
The Enzyme Function Initiative
|Biochemistry|2011|183
Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race
|Blood|2014|132
Inhibition of 12/15‐lipoxygenase as therapeutic strategy to treat stroke
|Annals of Neurology|2012|120
ENTPD-1 disrupts inflammasome IL-1β–driven venous thrombosis
|Journal of Clinical Investigation|2019|116
First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis
|Arteriosclerosis Thrombosis and Vascular Biology|2017|112